Monographie - Gemcitabine hydrochloride

Viimane versioon :
03/05/2024

Gemcitabine hydrochloride

Keemiline struktuur

Kaubanduslikud nimed erinevates maades

Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist

Accogem	Mehhiko
Antoril	Argentiina
Axigem	Saksamaa
Bendacitabin	Saksamaa
Binoptos	Mehhiko
Celzar	Maroko
Dercin	Rumeenia
Dhacibine	Malaisia
Emcitab	Kolumbia
Eriogem	Argentiina, Ecuador
Fotinex	Argentiina, Maroko
Gebina	Argentiina
Gebitan	Kolumbia
Gembio	Argentiina, Ecuador, Tšiili
Gemcimira	Maroko, Tšiili
Gemcit	Portugal
Gemcitabin	Saksamaa
Gemcitac	Tšiili
Gemko	Türgi
Gemsibin	Türgi
Gemsol	Austria
Gemtero	Maroko, Tšiili
Gemzar	Ameerika ühendriigid, Araabia Ühendemiraadid, Austraalia, Austria, Belgia, Brasiilia, Ecuador, Egiptus, Hispaania, Holland, Horvaatia, Iirimaa, Iraan, Island, Itaalia, Kanada, Kolumbia, Kreeka, Lõuna Aafrika Vabariik, Luksemburg, Malaisia, Maroko, Mehhiko, Norra, Poola, Portugal, Prantsusmaa, Rootsi, Rumeenia, Saksamaa, Sloveenia, Soome, Suurbritannia, Sveits, Taani, Tai, Tšiili, Tuneesia, Türgi, Ungari, Uus-Meremaa, Venetsueela
Gentabin	Kolumbia
Haxanit	Argentiina, Maroko
Lenfotabin	Mehhiko

Viited : Gemcitabine hydrochloride

	Tüüp	Avaldamine
1422	Ajaleht	Xu QA, Zhang Y, Trissel LA. Physical and chemical stability of gemcitabine hydrochloride solutions. J Am Pharm Assoc 1999 ; 39: 509-513.
1423	Ajaleht	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1501	Ajaleht	Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Int J Pharm 1999 ; 185: 113-121.
1520	Labor	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1611	Ajaleht	Chalmers JR, Bobek MB, Militello MA. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Am J Health-Syst Pharm 2001 ; 58: 504-506.
1625	Ajaleht	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1662	Ajaleht	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1663	Ajaleht	Ponton JL, Munoz C, Rey M, Val M. The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection. EJHP 2002 ; 1: 23-25.
1925	Ajaleht	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
1953	Ajaleht	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Ajaleht	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2009	Ajaleht	Trissel LA, Zhang Y. Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration. Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
2262	Ajaleht	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2344	Labor	Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution. Ebewe Pharma 2009
3262	Ajaleht	Manners S, Galettis P, de Souza P. Conditions causing gemcitabine crystallization. J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
3496	Labor	Gemcitabin Actavis solution - Stability Study Actavis 2009
3670	Ajaleht	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
4310	Ajaleht	Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M. Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs. Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.
4736	Ajaleht	Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 2023

Mentions Légales